JMP Securities initiated coverage on Zevra Therapeutics with a new price target

9/24/24 8:29:54 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

JMP Securities initiated coverage of Zevra Therapeutics with a rating of Mkt Outperform and set a new price target of $17.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ZVRA

Date	Price Target	Rating	Analyst
1/8/2025	$25.00	Overweight	Cantor Fitzgerald
10/7/2024	$20.00	Buy	Guggenheim
9/24/2024	$17.00	Mkt Outperform	JMP Securities
9/24/2024	$18.00 → $25.00	Buy	Maxim Group
4/2/2024	$12.00 → $18.00	Buy	Maxim Group
3/12/2024		Outperform	William Blair
3/17/2023	$12.00	Buy	Maxim Group